• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.04% Nasdaq Up0.20%

    ARCA biopharma, Inc. (ABIO)

    5.50 Up 0.09(1.65%) 11:56AM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    ARCA biopharma, Inc.
    11080 CirclePoint Road
    Suite 140
    Westminster, CO 80020
    United States - Map
    Phone: 720-940-2200
    Fax: 720-208-9261
    Website: http://www.arcabiopharma.com

    Index Membership:N/A
    Full Time Employees:16

    Business Summary 

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. The company has a collaboration agreement with Medtronic, Inc. for the support of Gencaro’s Phase IIB/III clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on ARCA biopharma, Inc.

    Key Executives 
    Dr. Michael R. Bristow M.D., Ph.D., 70
    Co-Founder, Chief Exec. Officer, Pres and Director
    Mr. Christopher D. Ozeroff , 56
    Sr. VP, Gen. Counsel and Sec.
    Mr. Brian L. Selby , 53
    Chief Accounting Officer and VP of Fin.
    Mr. Thomas A. Keuer , 56
    Chief Operating Officer
    Mr. Derek K. Cole ,
    VP of Investor Relations and Corp. Communications
    Monique Plamondon ,
    VP of Regulatory Affairs & QA
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders